Login to Your Account



U.S. Patent Disclosures


Tuesday, May 29, 2012
• Galena Biopharma Inc., of Lake Oswego, Ore., received a notice of allowance for a composition-of-matter patent related to folate-binding peptide (FBP) variants, alone or combined with the FBP vaccine E39.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription